Literature DB >> 2502766

Submandibular duct relocation for drooling: a 10-year experience with 194 patients.

W S Crysdale1, A White.   

Abstract

Management of drooling in the neurologically disabled individual has been accomplished with a team approach using surgical and nonsurgical methodology. Submandibular duct relocation has been the primary surgical procedure of choice in 194 patients during the past 10 years. Drooling has been reduced significantly in the majority of patients. Ranulas requiring intraoral sublingual gland excision occurred in 8% of patients. Persistent submandibular duct obstruction necessitating external excision of the submandibular gland occurred in 1% of the ducts relocated.

Entities:  

Mesh:

Year:  1989        PMID: 2502766     DOI: 10.1177/019459988910100114

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  17 in total

Review 1.  A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling.

Authors:  P H Jongerius; P van Tiel; J van Limbeek; F J M Gabreëls; J J Rotteveel
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

2.  [Botulinum toxin for the treatment of secretory disorders of the head and neck area].

Authors:  A Steffen
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

Review 3.  Hypersalivation: update of the German S2k guideline (AWMF) in short form.

Authors:  Armin Steffen; Wolfgang Jost; Tobias Bäumer; Dirk Beutner; Sabine Degenkolb-Weyers; Martin Groß; Maria Grosheva; Samer Hakim; Kai G Kahl; Rainer Laskawi; Rebekka Lencer; Jan Löhler; Thekla Meyners; Saskia Rohrbach-Volland; Rainer Schönweiler; Sara-Christina Schröder; Sebastian Schröder; Heidrun Schröter-Morasch; Maria Schuster; Susanne Steinlechner; Roland Urban; Orlando Guntinas-Lichius
Journal:  J Neural Transm (Vienna)       Date:  2019-04-10       Impact factor: 3.575

4.  Management of drooling in disabled patients with scopolamine patches.

Authors:  Abigail Mato; Jacobo Limeres; Inmaculada Tomás; Maria Muñoz; Concepción Abuín; Javier F Feijoo; Pedro Diz
Journal:  Br J Clin Pharmacol       Date:  2010-06       Impact factor: 4.335

Review 5.  [Treatment of sialorrhea with botulinum toxin: an overview].

Authors:  J Hagenah; K G Kahl; S Steinlechner; R Lencer; C Klein
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

6.  Long-lasting benefits of botulinum toxin type B in Parkinson's disease-related drooling.

Authors:  Giovanni Lagalla; Marzia Millevolte; Marianna Capecci; Leandro Provinciali; Maria Gabriella Ceravolo
Journal:  J Neurol       Date:  2009-04-23       Impact factor: 4.849

7.  Submandibular Duct Re-routing for Drooling in Neurologically Impaired Children.

Authors:  Prem Sagar; K K Handa; Sheffali Gulati; Rajeev Kumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-12-12

8.  Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea.

Authors:  Susanne Steinlechner; Christine Klein; Andreas Moser; Rebekka Lencer; Johann Hagenah
Journal:  Psychopharmacology (Berl)       Date:  2009-10-13       Impact factor: 4.530

9.  Persistent drooling: treatment by bilateral submandibular duct transposition and simultaneous sublingual gland excision.

Authors:  M Ethunandan; D W Macpherson
Journal:  Ann R Coll Surg Engl       Date:  1998-07       Impact factor: 1.891

10.  Deterioration of feeding behavior following surgical treatment of drooling.

Authors:  R D Stevenson; J H Allaire; P A Blasco
Journal:  Dysphagia       Date:  1994       Impact factor: 3.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.